Evaxion Biotech (EVAX) has released an update.
Maximize Your Portfolio with Data Driven Insights:
- Leverage the power of TipRanks' Smart Score, a data-driven tool to help you uncover top performing stocks and make informed investment decisions.
- Monitor your stock picks and compare them to top Wall Street Analysts' recommendations with Your Smart Portfolio
Evaxion Biotech, an AI-focused TechBio company, announced the launch of its enhanced AI-Immunology platform with an updated EDEN model to expedite the development of novel vaccines. The updated model can predict toxin antigens more accurately, which is crucial for creating effective bacterial vaccines. This advancement is set to improve the speed and efficiency of vaccine discovery, leveraging AI to meet urgent medical needs.
For further insights into EVAX stock, check out TipRanks’ Stock Analysis page.
